Cullinan Therapeutics Inc Sustainability Reports
Cullinan Oncology Inc. is a biopharmaceutical company focused on developing innovative targeted cancer therapies to address unmet medical needs in oncology.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US2300311063
2 reports from 2023 to 2024
Company Profile
Cullinan Therapeutics Inc
Cullinan Oncology Inc. is a biopharmaceutical company focused on developing innovative targeted cancer therapies to address unmet medical needs in oncology.
Reports